- Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain
-
Marino R, Magrini L, Orsini F, Russo V, Cardelli P, Salerno G, Hur M, Di Somma S, GREAT NETWORK
- KMID: 2373631
- Ann Lab Med.
- 2017 Mar;37(2):137-146.
- doi: 10.3343/alm.2017.37.2.137
BACKGROUND: High-sensitivity cardiac troponin I (hs-cTnI) and the soluble isoform of suppression of tumorigenicity 2 (sST2) are useful prognostic biomarkers in acute coronary syndrome (ACS). The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Can a Point-of-Care Troponin I Assay be as Good as a Central Laboratory Assay? A MIDAS Investigation
-
Peacock WF, Diercks D, Birkhahn R, Singer AJ, Hollander , Nowak R, Safdar B, Miller CD, Peberdy M, Counselman F, Chandra A, Kosowsky J, Neuenschwander J, Schrock J, Lee-Lewandrowski E, Arnold W, Nagurney J
- KMID: 2373569
- Ann Lab Med.
- 2016 Sep;36(5):405-412.
- doi: 10.3343/alm.2016.36.5.405
BACKGROUND: We aimed to compare the diagnostic accuracy of the Alere Triage Cardio3 Tropinin I (TnI) assay (Alere, Inc., USA) and the PathFast cTnI-II (Mitsubishi Chemical Medience Corporation, Japan) against... -
- CITED
-
- Close
- SHARE
-
- Close
